Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 301 to 350 of 2529

TitleReference numberPublishedLast updated
Bladder cancer: diagnosis and managementNG2
Bladder EpiCheck for detecting bladder cancer recurrenceMIB293
BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volumeMIB50
Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemiaTA450
Blinatumomab for previously treated Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal)TA686
Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activityTA589
Blinatumomab with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive minimal residual disease-negative B-cell precursor acute lymphoblastic leukaemiaTA1049
Blood transfusionNG24
Blood transfusionQS138
Bone-anchored cystourethropexyHTG6
Borderline personality disorder: recognition and managementCG78
Bortezomib and thalidomide for the first‑line treatment of multiple myelomaTA228
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantationTA311
Bortezomib for previously untreated mantle cell lymphomaTA370
Bortezomib for treating multiple myeloma after second or subsequent relapse (terminated appraisal)TA453
Bortezomib monotherapy for relapsed multiple myelomaTA129
Boston Keratoprosthesis Type I for corneal blindnessMIB91
Bosutinib for previously treated chronic myeloid leukaemiaTA401
Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal)TA576
Botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retentionHTG685
Botulinum toxin type A for the prevention of headaches in adults with chronic migraineTA260
Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excisionHTG171
Brain tumours (primary) and brain metastases in over 16sNG99
Brain tumours (primary) and brain metastases in over 16sQS203
Breast cancerQS12
Breast reconstruction using lipomodelling after breast cancer treatmentHTG280
Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphomaTA577
Brentuximab vedotin for treating CD30-positive Hodgkin lymphomaTA524
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphomaTA478
Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphomaTA1059
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphomaTA641
Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and overTA893
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphomaTA677
Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitorTA670
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinibTA571
Brodalumab for treating moderate to severe plaque psoriasisTA511
Brolucizumab for treating diabetic macular oedemaTA820
Brolucizumab for treating wet age-related macular degenerationTA672
Bronchial thermoplasty for severe asthmaHTG494
Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribingNG117
Bronchiolitis in childrenQS122
Bronchiolitis in children: diagnosis and managementNG9
Bronchoscopic thermal vapour ablation for upper-lobe emphysemaHTG517
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitisTA708
Bulevirtide for treating chronic hepatitis DTA896
Burosumab for treating X-linked hypophosphataemia in adultsTA993
Burosumab for treating X-linked hypophosphataemia in children and young peopleHST8
Butterfly iQ+ for diagnostic ultrasound imagingMIB254
C3 glomerulopathy in the native kidney: eculizumabESUOM49
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxelTA391

Results per page

  1. 10
  2. 25
  3. 50
  4. All